(0.06%) 5 103.27 points
(0.23%) 38 327 points
(0.08%) 15 940 points
(-1.24%) $82.81
(6.24%) $2.04
(0.00%) $2 347.10
(-0.28%) $27.46
(3.76%) $956.75
(-0.18%) $0.933
(-0.29%) $10.99
(-0.51%) $0.796
(1.69%) $93.43
3 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 12.15%
10.28% $ 2.36
Live Chart Being Loaded With Signals
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally...
Stats | |
---|---|
Tagesvolumen | 25 629.00 |
Durchschnittsvolumen | 12 951.00 |
Marktkapitalisierung | 4.47M |
EPS | $0 ( 2023-08-03 ) |
Nächstes Ertragsdatum | ( $0 ) 2024-05-02 |
Last Dividend | $0.850 ( 2022-12-19 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.270 |
ATR14 | $0.0230 (0.97%) |
Medigus Ltd. Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Medigus Ltd. Finanzdaten
Annual | 2022 |
Umsatz: | $91.86M |
Bruttogewinn: | $14.45M (15.73 %) |
EPS: | $-6.28 |
FY | 2022 |
Umsatz: | $91.86M |
Bruttogewinn: | $14.45M (15.73 %) |
EPS: | $-6.28 |
FY | 2021 |
Umsatz: | $10.12M |
Bruttogewinn: | $4.80M (47.45 %) |
EPS: | $3.00 |
FY | 2019 |
Umsatz: | $273 000 |
Bruttogewinn: | $-182 000 (-66.67 %) |
EPS: | $-54.44 |
Financial Reports:
No articles found.
Medigus Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0.850 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.850 | 2022-12-19 |
Last Dividend | $0.850 | 2022-12-19 |
Next Dividend | $0 | N/A |
Payout Date | 2022-12-28 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.850 | -- |
Avg. Dividend % Per Year | 0.87% | -- |
Score | 0.36 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2022 | $0.850 | 5.20% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.135 | 1.500 | -2.70 | -4.05 | [0 - 0.5] |
returnOnAssetsTTM | -0.218 | 1.200 | -7.27 | -8.72 | [0 - 0.3] |
returnOnEquityTTM | -0.527 | 1.500 | -6.97 | -10.00 | [0.1 - 1] |
payoutRatioTTM | -0.269 | -1.000 | -2.69 | 2.69 | [0 - 1] |
currentRatioTTM | 1.297 | 0.800 | 8.51 | 6.81 | [1 - 3] |
quickRatioTTM | 1.221 | 0.800 | 7.52 | 6.02 | [0.8 - 2.5] |
cashRatioTTM | 0.344 | 1.500 | 9.20 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.135 | -1.500 | 7.74 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -4.72 | 1.000 | -2.86 | -2.86 | [3 - 30] |
operatingCashFlowPerShareTTM | -4.67 | 2.00 | -1.557 | -3.11 | [0 - 30] |
freeCashFlowPerShareTTM | -5.75 | 2.00 | -2.88 | -5.75 | [0 - 20] |
debtEquityRatioTTM | 0.365 | -1.500 | 8.54 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.150 | 1.000 | -0.833 | -0.833 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0864 | 1.000 | -3.73 | -3.73 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.658 | 1.000 | -4.77 | -4.77 | [0.2 - 2] |
assetTurnoverTTM | 1.616 | 0.800 | 2.56 | 2.05 | [0.5 - 2] |
Total Score | -0.264 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.206 | 1.000 | -0.122 | 0 | [1 - 100] |
returnOnEquityTTM | -0.527 | 2.50 | -4.48 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -5.75 | 2.00 | -1.918 | -5.75 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -4.67 | 2.00 | -1.557 | -3.11 | [0 - 30] |
payoutRatioTTM | -0.269 | 1.500 | -2.69 | 2.69 | [0 - 1] |
pegRatioTTM | -0.00224 | 1.500 | -3.35 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0551 | 1.000 | -3.88 | 0 | [0.1 - 0.5] |
Total Score | -3.00 |
Medigus Ltd.
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, visualization solutions, and resistant cameras; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.